Ybrain, Inc.
Ybrain, Inc is dedicated to human happiness and values through brain science. They develop and commercialize neurotechnology solutions including electronic drugs, brain stimulation, and digital platforms for mental health care, research, and clinical applications. Their mission is to provide accessible mental health solutions for everyone, utilizing advanced technology, patents, and a comprehensive ecosystem suitable for home and clinical environments.
Industries
Nr. of Employees
small (1-50)
Patents
Electrical stimulation system for recognizing brain activation pattern and applying electrical stimulation to a user
US-10265524-B2
View DetailsMethod for stimulating living body more accurately and apparatus using the same
US-9381352-B2
View Details
Electrical stimulation system for recognizing brain activation pattern and applying electrical stimulation to a user
US-10265524-B2
View DetailsMethod for stimulating living body more accurately and apparatus using the same
US-9381352-B2
View DetailsProducts
Regulatory‑cleared home‑use transcranial electrical stimulation device for depression
Compact home‑use neuromodulation device cleared by national regulator for treatment of major depressive disorder, designed for supervised at‑home administration with remote monitoring capability.
Regulatory‑cleared peripheral/cranial nerve stimulation device for migraine relief
Portable TENS‑based device cleared for acute migraine relief intended for non‑invasive home or clinic use targeting trigeminal branches.
Digital EEG / qEEG diagnostic and analysis system
Wireless multichannel EEG system combined with automated qEEG analysis, normative database comparison and reporting for diagnostic assistance, screening and monitoring applications.
Miniaturized electroceutical module for OEM integration
Compact stimulation and sensing modules designed for embedding into consumer or medical devices to provide stress reduction, attention/cognition support and other neuromodulation functions.
High‑definition multichannel stimulation system
Multichannel stimulation device offering focused cortical targeting (HD‑tDCS) intended for clinical and research applications with regulatory authorization pathways pursued/completed.
Regulatory‑cleared home‑use transcranial electrical stimulation device for depression
Compact home‑use neuromodulation device cleared by national regulator for treatment of major depressive disorder, designed for supervised at‑home administration with remote monitoring capability.
Regulatory‑cleared peripheral/cranial nerve stimulation device for migraine relief
Portable TENS‑based device cleared for acute migraine relief intended for non‑invasive home or clinic use targeting trigeminal branches.
Digital EEG / qEEG diagnostic and analysis system
Wireless multichannel EEG system combined with automated qEEG analysis, normative database comparison and reporting for diagnostic assistance, screening and monitoring applications.
Miniaturized electroceutical module for OEM integration
Compact stimulation and sensing modules designed for embedding into consumer or medical devices to provide stress reduction, attention/cognition support and other neuromodulation functions.
High‑definition multichannel stimulation system
Multichannel stimulation device offering focused cortical targeting (HD‑tDCS) intended for clinical and research applications with regulatory authorization pathways pursued/completed.
Services
Cloud and device‑firmware platform connecting clinics and at‑home stimulation devices, enabling remote treatment control, telemetry, automated treatment workflows and large‑scale concurrent home treatment delivery.
Integration of EEG, HRV/ECG, activity/sleep tracking and self‑reported clinical scales into diagnostic assistance, reporting and remote monitoring systems with API/web integrations.
Provision and integration support for compact stimulation and sensing modules to embed electroceutical or monitoring capabilities into partner hardware and consumer devices.
Support for multi‑center confirmatory, exploratory and post‑market clinical studies including design, operationalization of at‑home randomized trials and regulatory clinical programs for neurostimulation indications.
Online clinical scale distribution and data‑collection platform for delivery of psychiatric scales and questionnaires with real‑time reporting and secure data handling for research and clinical use.
Cloud and device‑firmware platform connecting clinics and at‑home stimulation devices, enabling remote treatment control, telemetry, automated treatment workflows and large‑scale concurrent home treatment delivery.
Integration of EEG, HRV/ECG, activity/sleep tracking and self‑reported clinical scales into diagnostic assistance, reporting and remote monitoring systems with API/web integrations.
Provision and integration support for compact stimulation and sensing modules to embed electroceutical or monitoring capabilities into partner hardware and consumer devices.
Support for multi‑center confirmatory, exploratory and post‑market clinical studies including design, operationalization of at‑home randomized trials and regulatory clinical programs for neurostimulation indications.
Online clinical scale distribution and data‑collection platform for delivery of psychiatric scales and questionnaires with real‑time reporting and secure data handling for research and clinical use.
Expertise Areas
- Electronic therapeutics / electroceuticals
- Non‑invasive neuromodulation (tES, tDCS, tACS, tRNS, HD‑tDCS)
- Peripheral nerve stimulation (tNS/TENS)
- Wearable neuromodulation device engineering and OEM modules
Key Technologies
- Transcranial electrical stimulation (tES/tDCS/tACS/tRNS)
- High‑definition multichannel stimulation (HD‑tDCS, 16‑channel)
- Transcutaneous/peripheral nerve stimulation (tNS/TENS)
- Hybrid burst + DC stimulation waveforms
News & Updates
Ybrain, Inc presented at the BCI international conference on adaptive interfacing guidelines.
Ybrain, Inc announced clinical results showing the efficacy of Maindstem in improving postpartum depression.
Ybrain, Inc is developing a wearable robot for minimally invasive rehabilitation of paralysis.
Ybrain, Inc's electronic drug for depression has received the first approval in Korea, marking a significant milestone.
Ybrain, Inc reports promising clinical trial results on brain stimulation techniques for cognitive enhancement.
Ybrain, Inc achieved the first approval for an electronic drug for depression in Korea.
Ybrain, Inc presented at the BCI international conference on adaptive interfacing guidelines.
Ybrain, Inc announced clinical results showing the efficacy of Maindstem in improving postpartum depression.
Ybrain, Inc is developing a wearable robot for minimally invasive rehabilitation of paralysis.
Ybrain, Inc's electronic drug for depression has received the first approval in Korea, marking a significant milestone.
Ybrain, Inc reports promising clinical trial results on brain stimulation techniques for cognitive enhancement.
Ybrain, Inc achieved the first approval for an electronic drug for depression in Korea.